Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Burkitt's type translocation in multiple myeloma

F Solé1, S Woessner, P Acín

  • 1Laboratori de Citologia Hematológica, Hospital Central L'Aliaņca, Barcelona, Spain.

Leukemia Research
|September 1, 1994
PubMed
Summary

This study details a rare case of multiple myeloma exhibiting a specific chromosomal translocation, t(8;22), during disease progression. This finding is novel, as it’s the first reported instance of this particular genetic alteration in multiple myeloma.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Therapy-related myelodysplastic syndromes deserve specific diagnostic sub-classification and risk-stratification-an approach to classification of patients with t-MDS.

Leukemia·2020
Same author

miR-146a rs2431697 identifies myeloproliferative neoplasm patients with higher secondary myelofibrosis progression risk.

Leukemia·2020
Same author

Frequency and clinical impact of CDKN2A/ARF/CDKN2B gene deletions as assessed by in-depth genetic analyses in adult T cell acute lymphoblastic leukemia.

Journal of hematology & oncology·2018
Same author

Is there a pressing need for improving prognostication strategies in therapy-related myelodysplastic syndromes?

Leukemia·2017
Same author

Molecular characterisation of triple negative essential thrombocythaemia patients by platelet analysis and targeted sequencing.

Blood cancer journal·2016
Same author

Molecular predictors of response in patients with myeloid neoplasms treated with lenalidomide.

Leukemia·2016

Area of Science:

  • Hematology
  • Oncology
  • Cytogenetics

Background:

  • Multiple myeloma is a hematologic malignancy characterized by the proliferation of plasma cells.
  • Chromosomal translocations are common in multiple myeloma and can influence disease prognosis.
  • The t(8;22) translocation is typically associated with Burkitt's lymphoma, not multiple myeloma.

Observation:

  • A case of multiple myeloma was identified with a newly acquired t(8;22)(q24;q11) translocation during disease progression.
  • The translocation was detected during a phase of disease advancement, suggesting a role in progression.
  • Cytological features associated with this translocation were also examined.

Findings:

  • The presence of a t(8;22)(q24;q11) translocation in multiple myeloma is reported for the first time.

Related Experiment Videos

  • This translocation, usually seen in Burkitt's lymphoma, was associated with specific cytological characteristics in this myeloma case.
  • The occurrence of this translocation during disease progression may indicate its involvement in advancing the malignancy.

    • Implications:

    • This case expands the known spectrum of chromosomal abnormalities in multiple myeloma.
    • Understanding the link between t(8;22) and myeloma cytogenetics may offer new insights into disease mechanisms.
    • Further research is warranted to explore the clinical significance and therapeutic implications of this translocation in multiple myeloma.